Strategic Global Investments (STBV) Stock Analysis & Winston Score
Strategic Global Investments, Inc. is a small healthcare company that focuses on medical specialty products and services. It operates in the medical specialties segment of the healthcare industry, targeting niche markets within the broader health sector. The company is very small, with a market cap that rounds to essentially zero, which places it in the micro-cap or nano-cap category. The company generates revenue through product sales and services related to its medical specialty focus, reflected in a gross margin of around 44%. However, its operating margin is deeply negative, meaning it spends far more running the business than it earns — a common challenge for early-stage or restructuring companies. It appears to operate on a limited geographic scale. The biggest risk this company faces is financial sustainability: with a return on invested capital of nearly negative 49% and severe operating losses, it must either grow revenue significantly or cut costs sharply to survive long-term.
Winston Score: 20/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (6/30)
- Growth: Mixed (5/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Ownership data not available (not counted) (0/15)
Key Facts
Price: $0.00
Market Cap: $0M
Sector: Healthcare
Industry: Medical - Specialties
